# Aptevo Therapeutics Inc.: Form DEF 14A, filed Aug 31, 2026

- Company: [Aptevo Therapeutics Inc.](/companies/apvo.md) (CIK 1671584)
- Form: DEF 14A
- Filed: 2026-08-31
- Accepted by EDGAR: Aug 31, 2026, 17:29 ET
- Period: 2026-09-22
- Accession: 0001193125-26-376763
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671584/000119312526376763/apvo-20260831.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671584/000119312526376763/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671584/000119312526376763/apvo-20260831.htm

Filed Aug 31, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-376763. Last ingested by Listed: Nov 12, 2026, 21:52 ET. No prices; not investment advice.